Comparing Two Forms of Head Immobilization for Stereotactic Radiotherapy
- Conditions
- for Brain TumorsPatients Receiving Fractionated Stereotactic Radiotherapy
- Interventions
- Device: GTC frameDevice: Thermoplastic facemaskRadiation: Stereotactic radiation therapy
- First Posted Date
- 2006-05-22
- Last Posted Date
- 2016-11-29
- Target Recruit Count
- 83
- Registration Number
- NCT00328510
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients
- Conditions
- Central Nervous System NeoplasmsHead and Neck Neoplasms
- Interventions
- Drug: EPO906 (epothilone B)
- First Posted Date
- 2006-05-22
- Last Posted Date
- 2018-07-17
- Target Recruit Count
- 39
- Registration Number
- NCT00328458
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2006-05-22
- Last Posted Date
- 2023-12-19
- Target Recruit Count
- 32
- Registration Number
- NCT00328614
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Using the Active Breathing Control Device to Reduce Radiation Side Effects to Critical Structures in Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Device: Active Breathing Coordinator (ABC)Radiation: Radiation Therapy
- First Posted Date
- 2006-05-22
- Last Posted Date
- 2018-01-11
- Target Recruit Count
- 112
- Registration Number
- NCT00328783
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer
- Conditions
- Non-Small Cell Lung Carcinoma (NSCLC)
- Interventions
- Drug: ZD1839 (Iressa)Radiation: Thoracic Radiotherapy
- First Posted Date
- 2006-05-22
- Last Posted Date
- 2016-11-29
- Target Recruit Count
- 13
- Registration Number
- NCT00328562
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
- Conditions
- Kidney TransplantationPlasmapheresis
- Locations
- 🇺🇸
Columbia University, New York, New York, United States
🇺🇸Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
- Conditions
- Drug/Agent Toxicity by Tissue/OrganLung Cancer
- Locations
- 🇺🇸
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
Vaccine Therapy in Treating Patients With Metastatic Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2004-01-22
- Last Posted Date
- 2014-01-10
- Target Recruit Count
- 30
- Registration Number
- NCT00002817
- Locations
- 🇺🇸
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Conditions
- Drug/Agent Toxicity by Tissue/OrganLeukemia
- Locations
- 🇺🇸
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy
- Conditions
- Lung Cancer
- Locations
- 🇺🇸
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States